Axonyx Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4
  • Investments
  • 3

Axonyx General Information


Operator of a biopharmaceutical company. The company's activities include acquisition and development of proprietary pharmaceutical compounds and new technologies useful in the diagnosis and treatment of Alzheimer's disease, human memory disorders and prion-based illnesses such as Mad Cow Disease.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • 500 Seventh Avenue
  • 10th floor
  • New York, NY 10018
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axonyx Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axonyx‘s full profile, request access.

Request a free trial

Axonyx Executive Team (2)

Name Title Board Seat Contact Info
Marvin Hausman Chief Executive Officer & Chairman
Gosse Bruinsma MD President
To view Axonyx’s complete executive team members history, request access »

Axonyx Board Members (1)

Name Representing Role Since
000000 0000000 Axonyx Chief Executive Officer & Chairman 000 0000
To view Axonyx’s complete board members history, request access »

Axonyx Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 04-Oct-2006 0000000 000000 Biotechnology
0000 0000000000000 18-Jan-2005 0000 00.00 Pharmaceuticals
Oxis International 20-Jan-2004 Merger/Acquisition Pharmaceuticals
To view Axonyx’s complete investments and acquisitions history, request access »

Axonyx Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000000000000 18-Jan-2005 0000 00.00 Completed
  • 5 buyers
Oxis International 20-Jan-2004 Merger/Acquisition Completed
To view Axonyx’s complete exits history, request access »